Related Experiment Videos
Comparing angiographic coronary revascularization strategies: a 'natural' experiment
Insights
A restricted intracoronary stent policy did not increase clinical restenosis rates compared to usual practice. This real-world study found no significant difference in restenosis between groups with limited versus unrestricted stent availability.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Intracoronary stents are widely used in percutaneous transcatheter interventions.
- Stent availability can be influenced by economic factors and institutional policies.
- Clinical restenosis remains a significant concern after revascularization procedures.
Purpose of the Study:
- To evaluate the impact of restricted intracoronary stent availability on clinical restenosis rates.
- To compare restenosis outcomes in a 'real-world' setting with varying stent access.
- To assess the effectiveness of percutaneous transluminal coronary angioplasty (PTCA) with and without stenting.
Main Methods:
- Retrospective cohort study comparing patients undergoing angiographic revascularization.
- Two groups: 'restricted' (limited stent availability due to economic constraints) and 'usual' (unrestricted stent availability).
- Endpoint: first occurrence of death, myocardial infarction, coronary artery bypass grafting, repeat PTCA, or repeat angiography within nine months.
Main Results:
- No significant difference in clinical restenosis rates between the restricted (34.7%) and usual (37.9%) groups (P=0.524).
- Clinical restenosis rates were similar for patients undergoing PTCA without stenting (34.8%) and with stenting (39.4%) (P=0.368).
- Odds ratio for restenosis in the restricted group versus usual group was 0.915 (95% CI 0.694 to 1.206).
Conclusions:
- A restricted intracoronary stenting policy did not lead to increased clinical restenosis rates.
- Real-world data suggest that stent availability constraints did not adversely affect restenosis outcomes.
- The study supports the efficacy of PTCA with or without stenting in managing coronary artery disease.
Objective:
To study the impact of intracoronary stents on clinical restenosis in the 'real world'.
Design:
Retrospective comparison of the rates of clinical restenosis between two cohorts exposed to different strategies for percutaneous transcatheter intervention. The endpoint was the first of death, myocardial infarction, coronary artery bypass grafting, repeat percutaneous transluminal coronary angioplasty (PTCA) or repeat coronary angiography within nine months.
Setting:
Tertiary care cardiac referral centre serving a large, metropolitan population.
Patients:
Patients undergoing angiographic revascularization from January 1 to February 28, 1996 (the 'restricted' group [R], n=147) were compared with a before and after cohort (the 'usual' group [U], n=232, divided into those who underwent revascularization between November 1 and November 30, 1995, and those who underwent revascularization between April 1 and May 31, 1996).
Interventions:
The R group was revascularized during a period of economic constraint, which imposed a shortage on stent availability. The U cohort underwent revascularization before and after the shortage (an 'unrestricted' environment for stent usage).
Main Results:
There was no difference in clinical restenosis rates between the R (34.7%) and U (37.9%) groups (P=0.524, OR R/U=0.915, 95% CI 0.694 to 1.206). Also, the rate of clinical restenosis was the same among patients who underwent PTCA without stent insertion (34.8%) and those who received a stent (39.4%) (P=0.368, OR=1.13, 95% CI 0.87 to 1.44).
Conclusions:
At the authors' institution, a restricted stenting policy did not result in a higher clinical restenosis rate than that of usual practice.